Dystonia-deafness syndrome caused by ACTB p.Arg183Trp heterozygosity shows striatal dopaminergic dysfunction and response to pallidal stimulation.
Inger Marie SkogseidOddveig RøsbyAne KonglundJames P ConnellyBård NedregaardGreg Eigner JablonskiNadja KvernmoAsbjørg Stray-PedersenJoel C GloverPublished in: Journal of neurodevelopmental disorders (2018)
In this patient with dystonia-deafness syndrome caused by ACTB p.Arg183Trp heterozygosity, unprecedented brain imaging findings strongly indicate striatal neuronal/dopaminergic dysfunction as the underlying cause of the dystonia. Pallidal stimulation provided a substantial improvement of the severe generalized dystonia, which is largely sustained at 4-year follow-up, and we advise this treatment to be considered in such patients. We hypothesize that the pleiotropic manifestations of the dystonia-deafness syndrome caused by this mutation derive from diverse developmental functions of beta-actin in neural crest migration and proliferation (facial dysmorphogenesis), hair cell stereocilia function (infant-onset deafness), and altered synaptic activity patterns associated with pubertal changes in striatal function (adolescent-onset dystonia). The temporal differences in developmental onset are likely due to varying degrees of susceptibility and of compensatory upregulation of other actin variants in the affected structures.
Keyphrases
- deep brain stimulation
- parkinson disease
- early onset
- case report
- end stage renal disease
- functional connectivity
- high resolution
- chronic kidney disease
- ejection fraction
- oxidative stress
- mental health
- single cell
- newly diagnosed
- resting state
- young adults
- gene expression
- prognostic factors
- poor prognosis
- cell proliferation
- cell migration
- cell therapy
- dna methylation
- bone marrow
- combination therapy
- replacement therapy
- long non coding rna